In sensitive cells, verotoxin 1 (VT1) utilizes a globotriaosylceramide receptor-dependent retrograde transport pathway from the cell surface to the Golgi/endoplasmic reticulum (ER). The VT1 A subunit (VTA) is an RNA glycanase. Although translocation of VTA from the ER to the cytosol is considered the route for protein synthesis inhibition, cell-based evidence is lacking. A dual-fluorescent-labelled VT1 holotoxin was constructed to simultaneously monitor VTA and VT1 B subunit (VTB) intracellular transport. By confocal microscopy, VTA/VTB subunits remained associated throughout the retrograde transport pathway without cytosolic staining. However, in [125I]VT1-treated cells, the selective cytosolic translocation (4 %) of the activated form of VTA, VTA1, was demonstrated for the first time by monitoring [125I]VTA1 release after plasma membrane permeabilization by streptolysin O (SLO). Lactacystin, a proteasome inhibitor, increased cytosolic VTA1 and enhanced VT1 cytotoxicity. VT1 ER arrival coincided with cytosolic VTA1 detection. Brefeldin A and 16 °C, conditions which inhibit VT1 retrograde transport to the Golgi/ER, prevented VTA1 cytosolic translocation; however, these treatments did not completely prevent VT1-induced protein synthesis inhibition. Thus, efficient cytosolic translocation of VTA1 requires transport to the Golgi/ER, but alternative minor escape pathways for protein synthesis inhibition may operate when transport to the Golgi/ER is prevented. Inhibition of protein synthesis was time and dose dependent, and not necessarily a valid index of subsequent cytopathology. Only protein synthesis inhibition following >3 h VT1 exposure correlated with eventual cell cytotoxicity. Extrapolation of translocated cytosolic VTA1 values indicates that about one molecule of translocated VTA1 per cell is sufficient to inhibit protein synthesis and kill a cell.
ArabS.,
LingwoodC.1998; Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to Verotoxin: sodium butyrate or selection of drug resistance may induce nuclear toxin targeting via globotriaosyl ceramide fatty acid isoform traffic. J Cell Physiol 177:646–660
BaravalleG.,
SchoberD.,
HuberM.,
BayerN.,
MurphyR. F.,
FuchsR.2005; Transferrin recycling and dextran transport to lysosomes is differentially affected by bafilomycin, nocodazole, and low temperature. Cell Tissue Res 320:99–113
DeeksE. D.,
CookJ. P.,
DayP. J.,
SmithD. C.,
RobertsL. M.,
LordJ. M.2002; The low lysine content of ricin A chain reduces the risk of proteolytic degradation after translocation from the endoplasmic reticulum to the cytosol. Biochemistry 41:3405–3413
FalguieresT.,
MallardF.,
BaronC.,
HanauD.,
LingwoodC.,
GoudB.,
SalameroJ.,
JohannesL.2001; Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol Biol Cell 12:2453–2468
FujiiJ.,
MatsuiT.,
HeatherlyD. P.,
SchlegelK. H.,
LoboP. I.,
YutsudoT.,
CiraoloG. M.,
MorrisR. E.,
ObrigT.2003; Rapid apoptosis induced by Shiga toxin in HeLa cells. Infect Immun 71:2724–2735
FujinagaY.,
WolfA. A.,
RodighieroC.,
WheelerH.,
TsaiB.,
AllenL.,
JoblingM. G.,
RapoportT.,
HolmesR. K.,
LencerW. I.2003; Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to ER. Mol Biol Cell 14:4783–4793
HaicheurN.,
BenchetritF.,
AmessouM.,
LeclercC.,
FalguieresT.,
FayolleC.,
BismuthE.,
FridmanW. H.,
JohannesL.,
TartourE.2003; The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization. Int Immunol 15:1161–1171
HarrisonL. M.,
van den HoogenC.,
van HaaftenW. C.,
TeshV. L.2005; Chemokine expression in the monocytic cell line THP-1 in response to purified Shiga toxin 1 and/or lipopolysaccharides. Infect Immun 73:403–412
HazesB.,
ReadR. J.1997; Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells. Biochemistry 36:11051–11054
HeadS. C.,
KarmaliM. A.,
LingwoodC. A.1991; Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits: evidence for B subunit modulation of A subunit function. J Biol Chem 266:3617–3621
Heath-EngelH. M.,
LingwoodC. A.2003; Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker. Angiogenesis 6:129–141
HoeyD. E. E.,
CurrieC.,
LingwoodC. A.,
GallyD. L.,
SmithD. G. E.2003; Binding of verotoxin 1 to primary intestinal epithelial cells expressing Gb3 results in trafficking of toxin to lysosomal compartments. Cell Microbiol 5:85–97
ItoH.,
YutsudoT.,
HirayamaT.,
TakedaY.1988; Isolation and some properties of A and B subunits of Vero toxin 2 and in vitro formation of hybrid toxins between subunits of Vero toxin I and Vero toxin 2 from Escherichia coli 0157 : H7. Microb Pathog 5:189–195
JacksonM. E.,
SimpsonJ. C.,
GirodA.,
PepperkokR.,
RobertsL. M.,
LordJ. M.1999; The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by Shiga-like toxin-1, during retrograde transport from the Golgi complex to the endoplasmic reticulum. J Cell Sci 112:467–475
KalejtaR. F.,
ShenkT.2003; Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc Natl Acad Sci U S A 100:3263–3268
KarmaliM. A.,
SteeleB. T.,
PetricM.,
LimC.1983; Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1:619–620
KhineA. A.,
LingwoodC. A.1994; Capping and receptor mediated endocytosis of cell bound verotoxin (Shiga-like toxin) 1: chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization. J Cell Physiol 161:319–332
KhineA. A.,
TamP.,
NutikkaA.,
LingwoodC. A.2004; Brefeldin A and filipin distinguish two globotriaosyl ceramide/verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity. Glycobiology 14:701–712
LaPointeP.,
WeiX.,
GariepyJ.2005; A role for the protease-sensitive loop region of Shiga-like toxin 1 in the retrotranslocation of its A1 domain from the endoplasmic reticulum lumen. J Biol Chem 280:23310–23318
LauvrakS. U.,
TorgersenM. L.,
SandvigK.2004; Efficient endosome-to-Golgi transport of Shiga toxin is dependent on dynamin and clathrin. J Cell Sci 117:2321–2331
LeaN.,
LordJ. M.,
RobertsL. M.1999; Proteolytic cleavage of the A subunit is essential for maximal cytotoxicity of Escherichia coli O157 : H7 Shiga-like toxin-1. Microbiology 145:999–1004
LeeR. J.,
LiuC. W.,
HartyC.,
McCrackenA. A.,
LatterichM.,
RomischK.,
DeMartinoG. N.,
ThomasP. J.,
BrodskyJ. L.2004; Uncoupling retro-translocation and degradation in the ER-associated degradation of a soluble protein. EMBO J 23:2206–2215
LingwoodC. A.1993; Verotoxins and their glycolipid receptors. In Advances in Lipid Research vol 25 Sphingolipids Part A: Functions and Breakdown Products pp 189–212 Edited by
BellR.,
HannunY. A.,
MerrillA.Jr
San Diego: Academic Press;
Lippincott-SchwartzJ.,
YuanL.,
BonifacinoJ.,
KlausnerR.1989; Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 56:801–813
Lippincott-SchwartzJ.,
YuanL.,
TipperC.,
AmherdtM.,
OrciL.,
KlausnerR. D.1991; Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell 67:601–616
LlorenteA.,
LauvrakS. U.,
van DeursB.,
SandvigK.2003; Induction of direct endosome to endoplasmic reticulum transport in Chinese hamster ovary (CHO) cells (LdlF) with a temperature-sensitive defect in epsilon-coatomer protein (epsilon-COP. J Biol Chem 278:35850–35855
MallardF.,
AntonyC.,
TenzaD.,
SalameroJ.,
GoudB.,
JohannesL.1998; Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of Shiga toxin B-fragment transport. J Cell Biol 143:973–990
MeadP. S.,
SlutskerL.,
DietzV.,
McCaigL. F.,
BreseeJ. S.,
ShapiroC.,
GriffinP. M.,
TauxeR. V.1999; Food-related illness and death in the United States. Emerg Infect Dis 5:607–625
NoakesK. L.,
TeisserencH. T.,
LordJ. M.,
DunbarP. R.,
CerundoloV.,
RobertsL. M.1999; Exploiting retrograde transport of Shiga-like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway. FEBS Lett 453:95–99
NutikkaA.,
Binnington-BoydB.,
LingwoodC. A.2003; Methods for the purification of Shiga toxin 1. In Methods in Molecular Medicine vol73 pp 187–195 Edited by
PhilpotD.,
Ebel.
Totowa, NJ: Humana Press;
RapakA.,
FalnesP. O.,
OlsnesS.1997; Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol. Proc Natl Acad Sci U S A 94:3783–3788
RodighieroC.,
TsaiB.,
RapoportT. A.,
LencerW. I.2002; Role of ubiquitination in retro-translocation of cholera toxin and escape of cytosolic degradation. EMBO Rep 3:1222–1227
SakiriR.,
RamegowaB.,
TeshV. L.1998; Shiga toxin type 1 activates tumor necrosis factor- α gene transcription and nuclear translocation of the transcriptional activators nuclear factor- k B and activator protein-1. Blood 92:558–566
SandvigK.,
van DeursB.1996; Endocytosis, intracellular transport and cytotoxic action of Shiga toxin and ricin: from basic cell biology to targeted drug delivery. Physiol Rev 76:949–966
SandvigK.,
OlnesS.,
BrownJ.,
PetersonO.,
van DeursB.1989; Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1. J Cell Biol 108:1331–1343
SandvigK.,
GarredØ.,
PrydzK.,
KozlovJ.,
HansenS.,
van DeursB.1992; Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 358:510–512
SaxenaS. K.,
O'BrienA. D.,
AckermanE. J.1989; Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N -glycosidases of 28 S RNA when microinjected into Xenopus oocytes. J Biol Chem 264:596–601
SmithD. C.,
SillenceD. J.,
FalguieresT.,
JarvisR. M.,
JohannesL.,
LordJ. M.,
PlattF. M.,
RobertsL. M.2006; The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol Biol Cell 17:1375–1387
TorgersenM. L.,
LauvrakS. U.,
SandvigK.2005; The A-subunit of surface-bound Shiga toxin stimulates clathrin-dependent uptake of the toxin. FEBS J 272:4103–4113
WernerE. D.,
BrodskyJ. L.,
McCrackenA. A.1996; Proteasome-dependent endoplasmic reticulum-associated protein degradation: an unconventional route to a familiar fate. Proc Natl Acad Sci U S A 93:13797–13801
WescheJ.,
RapakA.,
OlsnesS.1999; Dependence of ricin toxicity on translocation of the toxin A-chain from the endoplasmic reticulum to the cytosol. J Biol Chem 274:34443–34449
WhiteJ.,
JohannesL.,
MallardF.,
GirodA.,
GrillS.,
ReinschS.,
KellesP.,
EchardA.,
GoudB.,
StelzerE. H. K.1999; Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells. J Cell Biol 147:743–759
YuM.,
HaslamD. B.2005; Shiga toxin is transported from the endoplasmic reticulum following interaction with the luminal chaperone HEDJ/ERdj3. Infect Immun 73:2524–2532